Nureca Ratios

Nureca Ltd Ratios

The Nureca Ltd Ratios page provides a complete fundamental analysis of Nureca Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Nureca Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Nureca Ltd (NSE: NURECA, BSE: 543264) is currently trading at ₹295.20, with a market capitalization of ₹2.8B. As a major player in the Health technology sector and Medical specialties industry, Nureca Ltd remains a key stock for fundamental analysis using Nureca Ltd Ratios.

Nureca Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Nureca Ltd P/E ratio currently stands at 248.64, making it one of the most tracked metrics in Nureca Ltd Ratios.

Historically, the Nureca Ltd P/E ratio has shown strong fluctuations:

• 2024: 248.64
• 2023: 0
• 2022: 0
• 2021: 30.30
• 2020: 9.71

The rising Nureca Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Nureca Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 1.08.

Historical P/B trend:

• 2024: 1.08
• 2023: 1.32
• 2022: 1.54
• 2021: 6.70

Nureca Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Nureca Ltd P/S ratio currently stands at 1.92, an important part of Nureca Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 1.92
• 2023: 2.78
• 2022: 2.70
• 2021: 5.33

A stable or declining Nureca Ltd P/S ratio indicates cautious market sentiment.

Nureca Ltd Price to Cash Flow Ratio (P/CF)

The Nureca Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Nureca Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 37.91
• 2022: 26.49
• 2021: 272.15
• 2020: 13.17

The declining Nureca Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Nureca Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Nureca Ltd EV currently stands at ₹868.89M, representing the total company valuation including debt.

Historical EV trend:

• 2024: 868.89M
• 2023: 1.14B
• 2022: 1.72B
• 2021: 12.49B

Nureca Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Nureca Ltd EV/EBITDA ratio is currently 0, a key metric in Nureca Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 21.47

Stable Nureca Ltd EV/EBITDA indicates balanced valuation.

Nureca Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Nureca Ltd D/E ratio is currently 0.03, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.03
• 2023: 0.01
• 2022: 0.02
• 2021: 0.02

Nureca Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Nureca Ltd ROE currently stands at 0.44%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 0.44
• 2023: -0.92
• 2022: -4.14
• 2021: 24.55

Declining ROE indicates pressure on profitability.

Nureca Ltd Ratios Analysis Summary

The Nureca Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Nureca Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Nureca Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.